David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Director

Board

AU·ASX

Arovella Therapeutics Limited

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the full record of transactions filed by David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust, Director. Officer active across 1 companies, notably Arovella Therapeutics Limited. Aggregated, 1 disclosures have been recorded. Regulator: ASX. The full history is accessible without signup.

Declarations1 total

Executives●OtherAArovella Therapeutics Limited11ASX

D

David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trustDirector

ShareASX

ASX:2924-03085488-3A692486·1 May 2026

ASX ↗

1 of 1 declaration

About David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

David John Williams is a Board Member at Arovella Therapeutics Limited. In this role, he participates in the governance of the company and in strategic decision-making. His experience and skills are valuable for the development and growth of Arovella.